Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Dianthus Therapeutics, Inc. shareholders
As of Jun 30, 2026, 260 institutions reported holding Dianthus Therapeutics, Inc. Largest: Fidelity, T. Rowe Price and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Dianthus Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 8.2M | +432K | Aug 13, 2026 | |
| T. Rowe Price | 6.4M | +3.96M | Aug 14, 2026 | |
| BlackRock | 4.12M | +948K | Aug 7, 2026 | |
| Wellington | 3.23M | +634K | Aug 14, 2026 | |
| Vanguard | 3.09M | +408K | Aug 13, 2026 | |
| Fairmount Funds Management LLC | 2.54M | no change | Aug 14, 2026 | |
| State Street | 2.36M | +959K | Aug 7, 2026 | |
| Avidity Partners Management LP | 2.1M | −2.1M | Aug 14, 2026 | |
| Octagon Capital Advisors LP | 1.84M | −105K | Aug 14, 2026 | |
| TCG Crossover Management, LLC | 1.68M | no change | Aug 14, 2026 |